{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:00:12Z","timestamp":1792144812410,"version":"4.4.0"},"reference-count":165,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immune surveillance is a central function of the immune system that prevents tumor initiation and progression. This process depends on the coordinated activity of innate and adaptive immune responses to recognize and eliminate transformed cells. However, pathological conditions can disrupt immune cell functions, impair immune surveillance, and facilitate tumor immune evasion. Chronic comorbidities, including obesity, type 2 diabetes mellitus (T2DM), non- alcoholic fatty liver disease (NAFLD\/NASH), and cardiovascular disease (CVD), are increasingly prevalent among cancer patients and significantly influence tumor-immune interactions. These conditions promote systemic low-grade inflammation, metabolic alterations, immune dysfunction, T cell exhaustion, impaired antigen presentation, and the establishment of tolerogenic tissue microenvironments. Despite their relevance, comorbidities are often underrepresented in preclinical cancer models and insufficiently considered when assessing therapeutic responses. Emerging evidence suggests that chronic comorbidities modulate the efficacy and toxicity of immunotherapies that rely on immune activation. Integrating clinically relevant comorbidities into preclinical cancer models for the development of novel therapeutic strategies will be essential to improve immunosurveillance, limit tumor escape, and optimize personalized cancer immunotherapy outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1773872","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:45:16Z","timestamp":1772779516000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The impact of chronic comorbidities on cancer immunoediting: challenges and opportunities for immunotherapies"],"prefix":"10.3389","volume":"17","author":[{"given":"Kassandra Ofelia","family":"Rodr\u00edguez-Aguill\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica Lizeth","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny Misael","family":"Calvillo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rodr\u00edguez-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Mart\u00ednez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/35074122","article-title":"IFN\u03b3 and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1152\/physiol.00021.2024","article-title":"Low-grade chronic inflammation: a shared mechanism for chronic diseases","volume":"40","author":"Cifuentes","year":"2025","journal-title":"Physiology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3174","article-title":"Molecular mechanisms of cancer development in obesity","volume":"11","author":"Khandekar","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7607","article-title":"Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies","volume":"350","author":"Tsilidis","year":"2015","journal-title":"BMJ"},{"key":"B9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Sci (1979)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3754","article-title":"Nutrition, inflammation and cancer","volume":"18","author":"Zitvogel","year":"2017","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3754","article-title":"Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-24-0545","article-title":"Murine models of obesity-related cancer risk","volume":"18","author":"Raji","year":"2025","journal-title":"Cancer Prev Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-16-0359","article-title":"Social isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk","volume":"23","author":"Sumis","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9134","DOI":"10.3390\/ijms23169134","article-title":"Metformin mitigated obesity-driven cancer aggressiveness in tumor-bearing mice","volume":"23","author":"Chen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.10.013","article-title":"STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.12.026","article-title":"Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer","volume":"133","author":"Makowski","year":"2014","journal-title":"Gynecol Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12788","article-title":"Adipose tissue from metabolic syndrome mice induces an aberrant miRNA signature highly relevant in prostate cancer development","volume":"14","author":"Massillo","year":"2020","journal-title":"Mol Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5868","article-title":"Impacts of pre-existing diabetes mellitus on colorectal cancer in a mice model","volume":"12","author":"Lv","year":"2023","journal-title":"Cancer Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12147","article-title":"Impact of diabetes on promoting the growth of breast cancer","volume":"41","author":"Chou","year":"2021","journal-title":"Cancer Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo1673","article-title":"Diabetic hyperglycemia promotes primary tumor progression through glycation-induced tumor extracellular matrix stiffening","volume":"8","author":"Wang","year":"2022","journal-title":"Sci Adv"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-020-00389-z","article-title":"Epithelial mesenchymal transition and progression of breast cancer promoted by diabetes mellitus in mice are associated with increased expression of glycolytic and proteolytic enzymes","volume":"11","author":"Viedma-Rodr\u00edguez","year":"2020","journal-title":"Horm Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"8654","DOI":"10.1038\/s41467-025-63801-8","article-title":"Diabetes reshapes pancreatic cancer-associated endothelial niche by accelerating senescence","volume":"16","author":"Ling","year":"2025","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00018-022-04485-x","article-title":"Intestinal microbiota regulates diabetes and cancer progression by IL-1\u03b2 and NOX4 dependent signaling cascades","volume":"79","author":"Noureldein","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900573","article-title":"Pancreatic cancer triggers diabetes through TGF-\u03b2\u2013mediated selective depletion of islet \u03b2-cells","volume":"3","author":"Parajuli","year":"2020","journal-title":"Life Sci Alliance"},{"key":"B28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1530\/ERC-17-0529","article-title":"Attenuation of NK cells facilitates mammary tumor growth in streptozotocin-induced diabetes in mice","volume":"25","author":"Gajovic","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.03.010","article-title":"Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD","volume":"77","author":"Wabitsch","year":"2022","journal-title":"J Hepatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.04.015","article-title":"A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPAR\u03b1 and PCK1","volume":"36","author":"Gallage","year":"2024","journal-title":"Cell Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.07.010","article-title":"Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment","volume":"34","author":"Zhang","year":"2022","journal-title":"Cell Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.09.053","article-title":"Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC","volume":"175","author":"Grohmann","year":"2018","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3390\/cells12141853","article-title":"Tumor growth ameliorates cardiac dysfunction","volume":"12","author":"Awwad","year":"2023","journal-title":"Cells"},{"key":"B35","doi-asserted-by":"publisher","first-page":"17367","DOI":"10.3390\/ijms242417367","article-title":"Heart failure promotes cancer progression in an integrin \u03b21-dependent manner","volume":"24","author":"Langier Goncalves","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvae038","article-title":"Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice","volume":"120","author":"de Wit","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41392-023-01336-4","article-title":"Exosomes secreted from cardiomyocytes suppress the sensitivity of tumor ferroptosis in ischemic heart failure","volume":"8","author":"Yuan","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22711","article-title":"Obesity: A chronic low-grade inflammation and its markers","volume":"14","author":"Khanna","year":"2022","journal-title":"Cureus"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.312467","article-title":"B lymphocytes and adipose tissue inflammation","volume":"40","author":"Srikakulapu","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B41","first-page":"1","volume-title":"Adipokines and the immune system: an adipocentric view","author":"MacLaren","year":"2008"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0674","article-title":"Adipokines as emerging mediators of immune response and inflammation","volume":"3","author":"Lago","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.622468","article-title":"The role of the adipokine leptin in immune cell function in health and disease","volume":"11","author":"Kiernan","year":"2021","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2022.2129381","article-title":"Leptin\u2019s immune action: A review beyond satiety","volume":"52","author":"Abend Bardagi","year":"2023","journal-title":"Immunol Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade","volume":"25","author":"Wang","year":"2019","journal-title":"Nat Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"102181","DOI":"10.1016\/j.eclinm.2023.102181","article-title":"Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"64","author":"Caruso","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.09.064","article-title":"Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight","volume":"337","author":"K\u00f6rner","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1749-6632.2002.tb04262.x","article-title":"Hyperglycemia and insulin resistance: possible mechanisms","volume":"967","author":"Tom\u00e1s","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnutbio.2015.11.002","article-title":"Role of lipids in the metabolism and activation of immune cells","volume":"34","author":"Hubler","year":"2016","journal-title":"J Nutr Biochem"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.677550","article-title":"Adiponectin\/adipoR1 axis promotes IL-10 release by human regulatory T cells","volume":"12","author":"Ramos-Ram\u00edrez","year":"2021","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjw012","article-title":"Adiponectin: a versatile player of innate immunity","volume":"8","author":"Luo","year":"2016","journal-title":"J Mol Cell Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.12.058","article-title":"Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPAR\u03b1, PPAR\u03b3, and LXR","volume":"314","author":"Chinetti","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-253831","article-title":"Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response","volume":"29","author":"van Stijn","year":"2015","journal-title":"FASEB J"},{"key":"B56","doi-asserted-by":"publisher","first-page":"115082","DOI":"10.1016\/j.intimp.2025.115082","article-title":"Role of leptin and adiponectin in immune response and inflammation","volume":"161","author":"Liu","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O\u2019Neill","year":"2016","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2014.991311","article-title":"Adipose tissue macrophages: the inflammatory link between obesity and cancer","volume":"19","author":"Wagner","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.08.023","article-title":"The cellular and molecular basis of translational immunometabolism","volume":"43","author":"Norata","year":"2015","journal-title":"Immunity"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nature08636","article-title":"Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.876029","article-title":"ILC2s and adipose tissue homeostasis: progress to date and the road ahead","volume":"13","author":"Misawa","year":"2022","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0251-7","article-title":"Metabolic reprogramming of natural killer cells in obesity limits antitumor responses","volume":"19","author":"Michelet","year":"2018","journal-title":"Nat Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-4100","article-title":"Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors","volume":"73","author":"Duraiswamy","year":"2013","journal-title":"Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0220-9","article-title":"Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy","volume":"119","author":"Fumet","year":"2018","journal-title":"Br J Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210042","article-title":"Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function","volume":"219","author":"Dyck","year":"2022","journal-title":"J Exp Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1038\/s41467-024-47359-5","article-title":"Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk","volume":"15","author":"Piening","year":"2024","journal-title":"Nat Commun"},{"key":"B69","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s40425-019-0699-5","article-title":"The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients","volume":"7","author":"Donnelly","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S303707","article-title":"Obesity promotes tumor immune evasion in ovarian cancer through increased production of myeloid-derived suppressor cells via IL-6","volume":"13","author":"Yang","year":"2021","journal-title":"Cancer Manag Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth","year":"2019","journal-title":"Br J Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01552","article-title":"Nrf2 is a central regulator of metabolic reprogramming of myeloid-derived suppressor cells in steady state and sepsis","volume":"9","author":"Ohl","year":"2018","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00949","article-title":"Myeloid-derived suppressor cells: ductile targets in disease","volume":"10","author":"Consonni","year":"2019","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.2174\/1573399815666191024085838","article-title":"Type 2 diabetes and its impact on the immune system","volume":"16","author":"Berbudi","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000047338","article-title":"Unraveling the connection: Inflammatory markers and diabetes mellitus pathogenesis","volume":"105","author":"Obeagu","year":"2026","journal-title":"Medicine"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-024-00741-6","article-title":"Impact of hyperglycemia on immune cell function: a comprehensive review","volume":"15","author":"Lee","year":"2024","journal-title":"Diabetol Int"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2174\/1381612811319320005","article-title":"Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases","volume":"19","author":"Fiorentino","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.02.103","article-title":"The potential pathogenic role of IL-17\/Th17 cells in both type 1 and type 2 diabetes mellitus","volume":"101","author":"Abdel-Moneim","year":"2018","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2020.97904","article-title":"Proinflammatory cytokine polarization in type 2 diabetes","volume":"45","author":"Bahgat","year":"2020","journal-title":"Cent Eur J Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-13-1","article-title":"Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease","volume":"13","author":"Madhumitha","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062418","article-title":"Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes","volume":"8","author":"Berrou","year":"2013","journal-title":"PloS One"},{"key":"B82","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.it.2025.02.014","article-title":"Diabetes can impact cellular immunity in solid tumors","volume":"46","author":"Garstka","year":"2025","journal-title":"Trends Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3116","article-title":"Type 2 diabetes mellitus and efficacy outcomes from immune checkpoint blockade in patients with cancer","volume":"29","author":"Cortellini","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu Rev Pathology: Mech Disease"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-013-9468-6","article-title":"Immune and inflammatory pathways in NASH","volume":"7","author":"Ganz","year":"2013","journal-title":"Hepatol Int"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1445634","article-title":"Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes","volume":"15","author":"Cebi","year":"2024","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/antiox10020174","article-title":"Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy","volume":"10","author":"Arroyave-Ospina","year":"2021","journal-title":"Antioxidants"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat Metab"},{"key":"B89","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","article-title":"Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism","volume":"1","author":"Lefere","year":"2019","journal-title":"JHEP Rep"},{"key":"B90","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20221271","article-title":"Inflammatory processes involved in NASH-related hepatocellular carcinoma","volume":"43","author":"Cannito","year":"2023","journal-title":"Biosci Rep"},{"key":"B94","doi-asserted-by":"publisher","first-page":"12906","DOI":"10.3390\/ijms232112906","article-title":"The role of inflammation in cardiovascular disease","volume":"23","author":"Henein","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","first-page":"69S","DOI":"10.1177\/0003319708320761","article-title":"Endothelial injury and repair: A novel theory for atherosclerosis","volume":"59","author":"Mannarino","year":"2008","journal-title":"Angiology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.3390\/ijms23063346","article-title":"Pathophysiology of atherosclerosis","volume":"23","author":"Jebari-Benslaiman","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1083\/jcb.201412052","article-title":"Recent insights into the cellular biology of atherosclerosis","volume":"209","author":"Tabas","year":"2015","journal-title":"J Cell Biol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-020-00251-y","article-title":"Metabolic reprogramming in macrophage responses","volume":"9","author":"Liu","year":"2021","journal-title":"biomark Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"100033","DOI":"10.1016\/j.pharmr.2024.100033","article-title":"Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: Any place for drug repurposing","volume":"77","author":"Avolio","year":"2025","journal-title":"Pharmacol Rev"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: How are they linked","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"23605","DOI":"10.1038\/s41598-025-05818-z","article-title":"Oxidative stress markers and inflammation in type 1 and 2 diabetes are affected by BMI, treatment type, and complications","volume":"15","author":"Cecerska-Hery\u0107","year":"2025","journal-title":"Sci Rep"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.767314","article-title":"Current and potential therapies targeting inflammation in NASH","volume":"12","author":"Albhaisi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B109","volume-title":"Dyslipidemia","author":"Pappan","year":"2025"},{"key":"B110","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/ijms17030327","article-title":"Endoplasmic reticulum stress and associated ROS","volume":"17","author":"Zeeshan","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-01062-4","article-title":"Cell death and inflammation during obesity: \u201cKnow my methods, WAT(son)","volume":"30","author":"Hildebrandt","year":"2023","journal-title":"Cell Death Differ"},{"key":"B112","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.arr.2015.06.004","article-title":"Damage-associated molecular patterns and their pathological relevance in diabetes mellitus","volume":"24","author":"Shin","year":"2015","journal-title":"Ageing Res Rev"},{"key":"B113","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.3390\/ijms19103104","article-title":"Danger-associated molecular patterns (DAMPs): molecular triggers for sterile inflammation in the liver","volume":"19","author":"Mihm","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0569","article-title":"The complex integration of T-cell metabolism and immunotherapy","volume":"11","author":"Madden","year":"2021","journal-title":"Cancer Discov"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e000725","DOI":"10.1136\/jitc-2020-000725","article-title":"Obesity diminishes response to PD-1-based immunotherapies in renal cancer","volume":"8","author":"Boi","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B116","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10555-011-9270-7","article-title":"Tumor immunosurveillance in human cancers","volume":"30","author":"Mlecnik","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"B117","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamaoncol.2015.1546","article-title":"Overweight, obesity, and postmenopausal invasive breast cancer risk","volume":"1","author":"Neuhouser","year":"2015","journal-title":"JAMA Oncol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults","volume":"348","author":"Calle","year":"2003","journal-title":"New Engl J Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/ERC-21-0107","article-title":"Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial","volume":"29","author":"Chau","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0795","article-title":"Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study","volume":"23","author":"Vidal","year":"2014","journal-title":"Cancer Epidemiology Biomarkers Prev"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-17-0495","article-title":"Metabolic obesity phenotypes and risk of breast cancer in postmenopausal women","volume":"26","author":"Kabat","year":"2017","journal-title":"Cancer Epidemiology Biomarkers Prev"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35318","article-title":"Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women\u2019s Health Initiative","volume":"130","author":"Chlebowski","year":"2024","journal-title":"Cancer"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0477","article-title":"Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial","volume":"15","author":"Gong","year":"2006","journal-title":"Cancer Epidemiology Biomarkers Prev"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2020121","article-title":"Beyond diabetes mellitus: role of metformin in non-muscle-invasive bladder cancer","volume":"63","author":"Wang","year":"2022","journal-title":"Singapore Med J"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-1046","article-title":"Diabetes mellitus and prostate cancer risk; A nationwide case\u2013control study within PCBaSe Sweden","volume":"22","author":"Fall","year":"2013","journal-title":"Cancer Epidemiology Biomarkers Prev"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.07.125","article-title":"Impact of diabetes mellitus on outcomes in patients with colon cancer","volume":"21","author":"Meyerhardt","year":"2003","journal-title":"J Clin Oncol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25360","article-title":"Association of diabetes mellitus with prostate cancer: Nested case\u2013control study (Prostate testing for cancer and Treatment study)","volume":"128","author":"Turner","year":"2011","journal-title":"Int J Cancer"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.224","article-title":"Diabetes and pancreatic cancer survival: a prospective cohort-based study","volume":"111","author":"Toriola","year":"2014","journal-title":"Br J Cancer"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0369","article-title":"Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan","volume":"167","author":"Tseng","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0000000000000432","article-title":"Dexrazoxane protects breast cancer patients with diabetes from chemotherapy-induced cardiotoxicity","volume":"349","author":"Sun","year":"2015","journal-title":"Am J Med Sci"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36939","article-title":"NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States","volume":"36","author":"Marrero","year":"2002","journal-title":"Hepatology"},{"key":"B132","doi-asserted-by":"publisher","first-page":"100591","DOI":"10.1016\/j.esmoop.2022.100591","article-title":"Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis","volume":"7","author":"Rimini","year":"2022","journal-title":"ESMO Open"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.11.011","article-title":"The impact of body mass index on the efficacy of anti-PD-1\/PD-L1 antibodies in patients with non-small cell lung cancer","volume":"139","author":"Ichihara","year":"2020","journal-title":"Lung Cancer"},{"key":"B135","doi-asserted-by":"publisher","first-page":"108442","DOI":"10.1016\/j.pharmthera.2023.108442","article-title":"Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link","volume":"247","author":"Delaye","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0161-2","article-title":"The \u2018obesity paradox\u2019 in action with cancer immunotherapy","volume":"15","author":"Lysaght","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0448","article-title":"Outcomes among patients with or without obesity and with cancer following treatment with immune checkpoint blockade","volume":"5","author":"Yoo","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B138","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40425-019-0527-y","article-title":"A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable","volume":"7","author":"Cortellini","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34918","article-title":"Association between diabetes mellitus and reduced efficacy of pembrolizumab in non\u2013small cell lung cancer","volume":"129","author":"Leshem","year":"2023","journal-title":"Cancer"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-023-00905-7","article-title":"Neutrophil (dys)function due to altered immuno-metabolic axis in type 2 diabetes: implications in combating infections","volume":"36","author":"Thimmappa","year":"2023","journal-title":"Hum Cell"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8781347","article-title":"Immune checkpoint inhibitor induced diabetes mellitus treated with insulin and metformin: evolution of diabetes management in the era of immunotherapy","volume":"2019","author":"Alrifai","year":"2019","journal-title":"Case Rep Oncol Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v14.i9.1622","article-title":"Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows","volume":"14","author":"Costante","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"12947","DOI":"10.3390\/ijms222312947","article-title":"Steatosis, steatohepatitis and cancer immunotherapy: an intricate story","volume":"22","author":"Cataldi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-20-0200","article-title":"Immune checkpoint inhibition is safe and effective for liver cancer prevention in a mouse model of hepatocellular carcinoma","volume":"13","author":"Chung","year":"2020","journal-title":"Cancer Prev Res"},{"key":"B145","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaccao.2020.08.007","article-title":"Immune checkpoint inhibitor therapy aggravates T cell\u2013driven plaque inflammation in atherosclerosis","volume":"2","author":"Poels","year":"2020","journal-title":"JACC CardioOncol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1604989","article-title":"The impact of immune checkpoint inhibition on atherosclerosis in cancer patients","volume":"16","author":"Han","year":"2025","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.049981","article-title":"Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque","volume":"142","author":"Drobni","year":"2020","journal-title":"Circulation"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2013.245","article-title":"Mitigating the toxic effects of anticancer immunotherapy","volume":"11","author":"Gangadhar","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.5.2727","article-title":"Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ Cell responses","volume":"170","author":"Murphy","year":"2003","journal-title":"J Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140116","article-title":"Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice","volume":"211","author":"Mirsoian","year":"2014","journal-title":"J Exp Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.812702","article-title":"Immunotherapeutic strategies in cancer and atherosclerosis\u2014Two sides of the same coin","volume":"8","author":"Nettersheim","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B152","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/iub.2180","article-title":"Cell transfer-based immunotherapies in cancer: A review","volume":"72","author":"Gorabi","year":"2020","journal-title":"IUBMB Life"},{"key":"B153","doi-asserted-by":"publisher","first-page":"108528","DOI":"10.1016\/j.diabres.2020.108528","article-title":"Insulin resistance and obesity affect monocyte-derived dendritic cell phenotype and function","volume":"170","author":"Paccosi","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2020.02.022","article-title":"Turning Cold into Hot: Firing up the Tumor Microenvironment","volume":"6","author":"Duan","year":"2020","journal-title":"Trends Cancer"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280189","article-title":"Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell Malignancies","volume":"107","author":"Dos Santos","year":"2022","journal-title":"Haematologica"},{"key":"B156","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","article-title":"Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy","volume":"22","author":"Morris","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00262-025-04165-2","article-title":"Tertiary lymphoid structures gene signature predicts response to immunotherapy plus chemotherapy in advanced non-small cell lung cancer","volume":"74","author":"Du","year":"2025","journal-title":"Cancer Immunology Immunother"},{"key":"B158","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40959-024-00290-6","article-title":"Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological Malignancies","volume":"10","author":"Daryanani","year":"2024","journal-title":"Cardio-Oncology"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00266.2012","article-title":"Inflammation during obesity is not all bad: evidence from animal and human studies","volume":"304","author":"Ye","year":"2013","journal-title":"Am J Physiology-Endocrinology Metab"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag0945","article-title":"Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2","volume":"10","author":"Incio","year":"2018","journal-title":"Sci Transl Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.3311","article-title":"Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody","volume":"25","author":"Vonderheide","year":"2007","journal-title":"J Clin Oncol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.03.010","article-title":"Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis \u2013 implications for cardiovascular safety","volume":"168","author":"Winnik","year":"2013","journal-title":"Int J Cardiol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000538","article-title":"Cardiovascular oncology: exploring the effects of targeted cancer therapies on atherosclerosis","volume":"29","author":"Seijkens","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"New Engl J Med"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.88","article-title":"Tyrosine kinase-targeting drugs-associated heart failure","volume":"116","author":"Gronich","year":"2017","journal-title":"Br J Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1773872\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:45:19Z","timestamp":1772779519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1773872\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":165,"alternative-id":["10.3389\/fimmu.2026.1773872"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1773872","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"article-number":"1773872"}}